Bonothyrk caps #60
- $76.85
- 2 or more $72.93
- 3 or more $70.57
- Availability:In Stock
Notice: Undefined variable: short_description in /home/innuenze/domains/farmacy-houses.com/public_html/catalog/view/theme/tt_angara3/template/product/product.tpl on line 105
The complex of peptide fractions obtained from the parathyroid glands of young animals. Isolated peptides have a selective effect on parathyroid cells, normalize metabolism in them, and increase their functional activity. A clinical study established the effectiveness of the drug Bonothyrk for restoring the functional activity of the parathyroid glands with disorders of various genesis, including hyperparathyroidism, including osteoporosis, demineralization of bone tissue, urolithiasis, muscle weakness, as well as hypoparathyroidism, including hypocalcemia, muscle cramps muscle numbness.
Recommended by
with osteoporosis
with demineralization of bone tissue
with urolithiasis
with muscle weakness due to hyperplasia of the parathyroid glands
with muscle cramps, numbness of muscles caused by hypocalcemia
Composition (per 1 capsule): A-21 peptide complex (parathyroid peptides), microcrystalline cellulose (E460, anti-caking agent), gelatin (capsule), sugar beet (binding filler), lactose (water-holding filler), starch (stabilizer) ), Tween-80 (emulsifier), titanium dioxide (E171, colorant for capsules).
The daily dose contains: (2 capsules), 20 mg of the A-21 peptide complex.
Release form: 60/20 capsules of 0.2 g
Mode of application Bonothyrk
Adults take 1-2 capsules 1-2 times a day on an empty stomach 30 minutes before eating. Duration of admission is 1 month.